Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 255Neoplasms 220Carcinoma, Non-Small-Cell Lung 201Colorectal Neoplasms 146Prostatic Neoplasms 136Lung Neoplasms 118Ovarian Neoplasms 100Neoplasm Metastasis 100Multiple Myeloma 96Pancreatic Neoplasms 89Leukemia, Myeloid, Acute 80Squamous Cell Carcinoma of Head and Neck 70Melanoma 64Endometrial Neoplasms 64Stomach Neoplasms 59Recurrence 57Glioblastoma 55Brain Neoplasms 54Urinary Bladder Neoplasms 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 50Carcinoma, Hepatocellular 50Lymphoma 48Triple Negative Breast Neoplasms 47Carcinoma, Renal Cell 45Head and Neck Neoplasms 44Esophageal Neoplasms 44Glioma 43Lymphoma, Non-Hodgkin 42Hematologic Neoplasms 42Uterine Cervical Neoplasms 39

Interventions

plerixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neutropenia × 30 days × Clear all
NCT00967785 2026-05-22

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
20 enrolled

Agammaglobulinemia, Immunologic Deficiency Syndromes, Infections, Leukopenia, Neutropenia, Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡